News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dune Medical Devices Ltd.'s Breast Cancer Device Gets a Date With the FDA


4/6/2012 8:43:32 AM

The FDA's general & plastic surgery devices advisory panel is slated to convene June 21 for a hearing on Dune Medical's MarginProbe breast cancer diagnosis tool. Dune Medical Devices has a date with the FDA to review its pre-market approval application for the MarginProbe breast cancer detection device. The watchdog agency's general & plastic surgery devices advisory panel scheduled a hearing for June 21 to review the PMA data for the device, which uses electromagnetic waves to characterize human tissue in real time and "provides intra-operative information on the malignancy of the surface of the ex vivo lumpectomy specimen," according to the FDA.

Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES